SOLENO THERAPEUTICS
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
SOLENO THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1999-08-25
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.soleno.life
Total Employee:
11+
Status:
Active
Contact:
(650) 213-8444
Email Addresses:
[email protected]
Total Funding:
31.5 M USD
Similar Organizations
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Jack Schuler
Jack Schuler investment in Post-IPO Equity - Soleno Therapeutics
Ernest Mario
Ernest Mario investment in Post-IPO Equity - Soleno Therapeutics
Abingworth
Abingworth investment in Post-IPO Equity - Soleno Therapeutics
Oracle Investment Management Inc.
Oracle Investment Management Inc. investment in Post-IPO Equity - Soleno Therapeutics
Official Site Inspections
http://www.soleno.life Semrush global rank: 3.66 M Semrush visits lastest month: 3.87 K
- Host name: 145.0.153.160.host.secureserver.net
- IP address: 160.153.0.145
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Soleno Therapeutics"
About Us – Soleno Therapeutics
Our Priority. At Soleno, we are researching and developing medicines to treat rare genetic disorders, beginning with Prader-Willi syndrome (PWS), a rare and life-threatening …See details»
Team – Soleno Therapeutics
Ms. Budesheim joined Soleno as Vice President, People in January 2024 but had been consulting for Soleno since August 2021. She has more than 20 years of experience in human resources …See details»
Soleno Therapeutics - Crunchbase Company Profile
Organization. Soleno Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Press Releases - Soleno Therapeutics Inc.
Aug 19, 2024 Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024. Nov 06, 2024 ...See details»
Soleno Therapeutics Strengthens Leadership Team with Key …
Jan 24, 2024 About Soleno Therapeutics, Inc. Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s …See details»
Mission Statement, Vision, & Core Values (2024) of Soleno …
Nov 16, 2024 Mission Statement of Soleno Therapeutics, Inc. (SLNO) Mission Statement Overview Soleno Therapeutics, Inc. (SLNO) is committed to advancing innovative therapies …See details»
Release Details - Soleno Therapeutics Inc.
REDWOOD CITY, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel …See details»
For Patients and Families – Soleno Therapeutics
These individuals are at risk of suffering significant health and quality of life consequences, including morbid obesity and premature death without such controls in place. Expanded …See details»
Our involvement : social and environmental …
Discover Soleno's involvement in the community in organizations such as the Honoré-Mercier Foundation, the Haut-Richelieu-Rouville Foundation and the non-profit organization Civic Sponsorship of the Haut-Richelieu. Our products . Our …See details»
November 2023 | Soleno Therapeutics - investors.soleno.life
• Families with a child with PWS have low quality of life – Caregiver burden higher for caregivers of people with PWS than those with Alzheimer’s – Burden of care is highest after onset of …See details»
Soleno Therapeutics, Inc. (SLNO) - Yahoo Finance Canada
See the company profile for Soleno Therapeutics, Inc. (SLNO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Investor Presentations – Soleno Therapeutics Inc.
The Investor Relations website contains information about Soleno Therapeutics Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Residents can find clubs, organizations to fit - Solano Life
Aug 26, 2018 Service/Fraternal Organization Alooma Temple No. 212: Meets at 7 p.m. the second Friday of the month at 625…See details»
Careers – Soleno Therapeutics
An equal opportunity employer. As an equal opportunity employer, Soleno Therapeutics, Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection …See details»
Soleno Therapeutics Provides Corporate Update and Reports Third …
Sep 30, 2021 REDWOOD CITY, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company …See details»
Environmental leadership - Soleno
Mobilizing know-how to recover residual plastic materials. The Soleno innovation Pole was created in 2019 with the objective of attracting and federating multidisciplinary expertise in …See details»
Digene Corporation Job Description - soleno.life
Feb 6, 2024 highly motivated professional to join Soleno Therapeutics as Director of Patient Advocacy and Government Affairs ... our organization. Build relationships with key government …See details»
Digene Corporation Job Description - soleno.life
Jul 19, 2024 Soleno Therapeutics, Inc., based in Redwood City, California, is a clinical-stage biopharmaceutical company ... Proven track record of effectively and efficiently driving …See details»
Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION
SOLENO THERAPEUTICS, INC (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 834203309 (CUSIP Number) 09/30/2024 (Date of Event Which Requires …See details»